In turn, this resulted in a significant reduction in CDK2 and cyclin E kinase activities, ultimately causing tumor cells to arrest at the G1 phase and inhibiting the growth of LNCaP cells (Mueller et al., 1997). Here, CDK2 is linked to neoplasm.